AgomAb Therapeutics (AGMB) Payables (2024 - 2026)
Agomab Therapeutics' Payables came in at $13.77 million for Q2 2026.
Powered by 
Analysis
AgomAb Therapeutics (AGMB) Payables (2024 - 2026) Analysis & Trends
At the end of FY2025, Agomab Therapeutics' Payables was $11.6 million, up 33.1% from FY2024.
- Going back by year, Payables was $8.71 million in FY2024.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.53 Mn |
| Dec 31, 2025 | 12.06 Mn |
| Dec 31, 2024 | 8.38 Mn |
API Access
AgomAb Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=AGMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "AGMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=AGMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();